# @benzinga on YouTube

- **Type:** Video
- **Original URL:** https://youtube.com/watch?v=fR89dH5SDEk
- **Gondola URL:** https://gondola.cc/posts/68664230-benzinga-youtube
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/36e90d5012.jpg
- **Posted:** 2026-08-05T09:41:49.000+00:00
- **Account Owner:** Benzinga | News That Moves (@benzinga) — https://gondola.cc/benzinga

## Caption

Gilead Sciences Inc (GILD) — Q2 FY26 Earnings Call

Live coverage with Benzinga.

Q2 FY26 Results
EPS: -$6.75 (est. -$7.14) — inline
Revenue: $7.80B (est. $7.40B) — inline
Reported: 2026-08-04

Recent Quarters
Q1 FY26 (2026-05-07): EPS $2.03 vs est $1.91 · Rev $6.96B vs est $6.92B
Q4 FY25 (2026-02-10): EPS $1.86 vs est $1.83 · Rev $7.92B vs est $7.64B
Q3 FY25 (2025-10-30): EPS $2.47 vs est $2.14 · Rev $7.77B vs est $7.46B
Q2 FY25 (2025-08-07): EPS $2.01 vs est $1.95 · Rev $7.08B vs est $6.96B

About Gilead Sciences Inc
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
https://www.gilead.com · Foster City, CA, USA · 17,000 employees

Follow Benzinga
X: https://x.com/Benzinga
Facebook: https://www.facebook.com/Benzinga/
Instagram: https://www.instagram.com/benzinga/

⚠️ Disclaimer:
Investing in financial markets carries risk, and there are no guaranteed returns. All information is for educational purposes only and should not be taken as financial advice. Always do your own research and speak with a qualified financial advisor before making investment decisions. Only invest what you can afford to lose. Past performance does not guarantee future outcomes.

#earnings #GILD #stocks #benzinga

## Stats

- **Views:** 80
- **Likes:** 1
- **Shares:** 0
- **Comments:** 0

## Tags

benzinga, stocks, gild, earnings

---
Copyright (c) Gondola